Published in Int J Hematol Oncol Stem Cell Res on July 01, 2015
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood (2009) 23.52
IL-17 and Th17 Cells. Annu Rev Immunol (2009) 23.02
A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell (2000) 17.61
IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol (2007) 14.99
Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol (2007) 12.72
Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (1994) 8.69
IL-22 increases the innate immunity of tissues. Immunity (2004) 8.30
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature (2008) 8.22
CD4 T cells: fates, functions, and faults. Blood (2008) 7.03
Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol (2008) 6.76
IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol (2008) 6.41
Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell (2004) 5.50
Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med (2008) 4.95
Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol (2009) 4.73
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol (2009) 4.69
Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest (2009) 4.10
Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med (2006) 3.36
Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev (2001) 3.31
Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity (2003) 3.29
The MAPK signalling pathways and colorectal cancer. Lancet Oncol (2005) 3.10
Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum (2009) 2.80
IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol (2009) 2.77
Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem (2002) 2.73
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene (2002) 2.36
Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest (1996) 2.27
T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol (2000) 2.08
IL-22, not simply a Th17 cytokine. Immunol Rev (2013) 2.04
Recent advances in IL-22 biology. Int Immunol (2011) 1.85
Biology of human TH1 and TH2 cells. J Clin Immunol (1995) 1.84
Th17 cytokines and mucosal immunity. Immunol Rev (2008) 1.80
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci U S A (2010) 1.73
The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat Immunol (2001) 1.63
Multiparameter grouping delineates heterogeneous populations of human IL-17 and/or IL-22 T-cell producers that share antigen specificities with other T-cell subsets. Eur J Immunol (2011) 1.59
CD4⁺T cells: differentiation and functions. Clin Dev Immunol (2012) 1.56
TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol (2008) 1.49
IL-17 enhances tumor development in carcinogen-induced skin cancer. Cancer Res (2010) 1.45
Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia (2000) 1.45
Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A (2010) 1.45
Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci U S A (2009) 1.44
Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol (2009) 1.37
Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PLoS One (2012) 1.37
Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur J Immunol (2010) 1.36
Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clin Cancer Res (2008) 1.35
Childhood and adolescent lymphoid and myeloid leukemia. Hematology Am Soc Hematol Educ Program (2004) 1.35
Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection. Immunity (2013) 1.32
Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia. Clin Exp Immunol (2009) 1.30
Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. Eur J Immunol (1995) 1.30
Targeting the development and effector functions of TH17 cells. Semin Immunol (2008) 1.29
Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy. J Leukoc Biol (2005) 1.25
Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. J Immunol (2011) 1.24
Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production. Blood (2009) 1.18
Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma. Leukemia (2008) 1.16
Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity. Sci Transl Med (2014) 1.15
Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol Cell Biochem (2011) 1.14
Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther (2011) 1.09
Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer. J Clin Immunol (2012) 1.07
Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity. Clin Exp Rheumatol (2013) 1.06
Expression of Th17 cytokines in skin lesions of patients with psoriasis. J Huazhong Univ Sci Technolog Med Sci (2007) 1.04
Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Res Ther (2013) 1.03
Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome. PLoS One (2012) 0.99
Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus. Cell Immunol (2010) 0.99
Commentary: does immune suppression increase risk of developing acute myeloid leukemia? Leukemia (2011) 0.98
A novel role for IL-22R1 as a driver of inflammation. Blood (2010) 0.98
The role of the IL-22/IL-22R1 axis in cancer. Cytokine Growth Factor Rev (2014) 0.97
Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival. Cancer Immunol Immunother (2012) 0.96
IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis. J Neuroimmunol (2013) 0.95
Increased Th22 cells as well as Th17 cells in patients with adult T-cell acute lymphoblastic leukemia. Clin Chim Acta (2013) 0.94
IL-9 and Th9 cells: progress and challenges. Int Immunol (2013) 0.94
MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b. FASEB J (2002) 0.94
Interferon-gamma sensitizes human myeloid leukemia cells to death receptor-mediated apoptosis by a pleiotropic mechanism. J Biol Chem (2001) 0.91
T-cell prolymphocytic leukemia involving extramedullary sites. Am J Clin Pathol (2005) 0.90
Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis. Int J Rheum Dis (2013) 0.89
Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia. Cancer Sci (2014) 0.89
Functional diversity of human vaginal APC subsets in directing T-cell responses. Mucosal Immunol (2012) 0.87
Aberrant T helper 17 cells and related cytokines in bone marrow microenvironment of patients with acute myeloid leukemia. Clin Dev Immunol (2013) 0.87
Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments. Mediators Inflamm (2014) 0.87
The aryl hydrocarbon receptor (AhR) ligand VAF347 selectively acts on monocytes and naïve CD4(+) Th cells to promote the development of IL-22-secreting Th cells. Hum Immunol (2012) 0.86
Increased incidence of acute myeloid leukemia after liver transplantation? Description of three new cases and review of the literature. Transplantation (2004) 0.86
The latest treatment advances for acute myelogenous leukemia. Med Health R I (2003) 0.83
Human Th9 cells: inflammatory cytokines modulate IL-9 production through the induction of IL-21. Immunol Cell Biol (2010) 0.81
Elevated Th22 cells correlated with Th17 cells in peripheral blood of patients with acute myeloid leukemia. Int J Mol Sci (2014) 0.81
Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia. Am J Clin Pathol (2011) 0.81
[The prevalence of Th17 cells in patients with acute myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi (2010) 0.80
The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia. Hum Immunol (2013) 0.79
A brief review of the basics of immunology: the innate and adaptive response. Vet Clin North Am Small Anim Pract (2010) 0.79
Disruption of the IFN-gamma cytokine network in chronic lymphocytic leukemia contributes to resistance of leukemic B cells to apoptosis. Leuk Res (2000) 0.78
[Change of Th22 cells in peripheral blood of patients with primary immune thrombocytopenia and clinical implication]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2012) 0.77
Th1, Th2, Th17, and regulatory cytokines in children with different clinical forms of allergy. Adv Exp Med Biol (2013) 0.77
[The change of peripheral blood Th22 cells in patients with acute myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi (2012) 0.77
Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children. Arch Immunol Ther Exp (Warsz) (2005) 0.77
The potential protective role of the combination of IL-22 and TNF-α against genital tract Chlamydia trachomatis infection. Cytokine (2015) 0.77
[Change and significance of Th22 cells in patients with aplastic anemia]. Zhonghua Yi Xue Za Zhi (2013) 0.76
[Expression level of Th22 cells and its cytokines in patients with acute lymphoblastic leukemia and its significance]. Zhongguo Shi Yan Xue Ye Xue Za Zhi (2013) 0.76
Th22 Cells Contribution in Immunopathogenesis of Rheumatic Diseases. Iran J Allergy Asthma Immunol (2015) 0.76
Chronic lymphocytic leukemia and its impact on the immune system. Clin J Oncol Nurs (2002) 0.76
IL-22 Produced by T helper Cell 22 as a New player in the Pathogenesis of Immune Thrombocytopenia. Endocr Metab Immune Disord Drug Targets (2015) 0.75
Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia. Blood Cells Mol Dis (2012) 0.75
[Research progress on genes associated with transformation of myelodysplastic syndromes to acute myeloid leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi (2014) 0.75
HLA antigens and anti-sperm antibody production in Iranian vasectomized men. J Biomed Res (2015) 0.77
T-helper 22 cells as a new player in chronic inflammatory skin disorders. Int J Dermatol (2015) 0.77
Th22 Cells Contribution in Immunopathogenesis of Rheumatic Diseases. Iran J Allergy Asthma Immunol (2015) 0.76
The Effect of Lactobacillus acidophilus PTCC 1643 on Cultured Intestinal Epithelial Cells Infected with Salmonella enterica serovar Enteritidis. Osong Public Health Res Perspect (2017) 0.75
Targeting of crosstalk between tumor and tumor microenvironment by β-D mannuronic acid (M2000) in murine breast cancer model. Cancer Med (2017) 0.75
Hydroxycitric acid ameliorates inflammation and oxidative stress in mouse models of multiple sclerosis. Neural Regen Res (2016) 0.75
Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis. Iran J Allergy Asthma Immunol (2016) 0.75
The Biology of β-D-mannuronic acid (M2000) on Human Dendritic Cell Based on MicroRNA-155 and MicroRNA-221. Curr Drug Discov Technol (2016) 0.75
Monogenic Auto-inflammatory Syndromes: A Review of the Literature. Iran J Allergy Asthma Immunol (2016) 0.75
Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition. Invest New Drugs (2017) 0.75